Studying Heart Ablation After Left Atrial Closure in High-Bleeding-Risk Atrial Fibrillation Patients
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Chicago
- Study ID
- NCT07580937
- Status
- Completed
Conditions
- Atrial Arrhythmia
- Atrial Fibrillation
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Data collection — OTHERData collection on patient characteristics and comorbidities, baseline echocardiographic data, home medications including oral anticoagulation regimen, ablation data, left atrial appendage occlusion device data, and complication-related details from routine procedures and encounters
Study Details
The purpose of this multicenter study is to collect information from routine clinical practices for patients with left atrial appendage occlusion (LAAO) devices presenting for pulmonary vein isolation (PVI) or left atrial ablation. Assessment will include characterization of patient characteristics, procedural details, management of post-procedure anticoagulation, and clinical outcomes.
Key Dates
- Start date
- Mar 8, 2022
- Status verified
- May 2026
- Primary completion
- Dec 10, 2024
- Completion
- Mar 30, 2026
Study Design
- Enrollment
- 198 participants (actual)
Arms
- Arm: Individuals undergoing atrial ablation for routine careIndividuals undergoing any type of atrial fibrillation ablation or left atrial arrhythmia ablation for routine care
Primary Outcome Measure
Patient characteristics [ Time Frame: Month 0, baseline ]
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Loyola University | Chicago | Illinois | 60660 | - |
| Rush University Medical Center | Chicago | Illinois | 60612 | - |
| University of Chicago | Chicago | Illinois | 60637 | - |
| Northwestern University | Evanston | Illinois | 60208 | - |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | - |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | - |
| University of Michigan | Ann Arbor | Michigan | 48109 | - |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | - |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | - |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | - |
Find similar trials in Chicago, IL
By condition
By specialty
Related Studies
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- Minocycline Plus Amiodarone Versus Amiodarone Alone for the Prevention of Atrial Fibrillation After Cardiac SurgeryPHASE2 · Not Yet Recruiting · Baystate Medical Center · Melrose, Massachusetts
- Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial FibrillationPHASE4 · Recruiting · University of Illinois at Chicago · Chicago, Illinois
- CardioFocus HeartLight Post-Approval StudyRecruiting · CardioFocus · Tucson, Arizona